ROIV
NASDAQ · Biotechnology
Roivant Sciences Ltd
$34.01
+1.80 (+5.59%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+56.73%
1Y
+198.33%
YTD
+55.08%
Open$32.25
Previous Close$32.21
Day High$34.51
Day Low$32.00
52W High$32.79
52W Low$10.71
Volume—
Avg Volume5.23M
Market Cap22.61B
P/E Ratio—
EPS$-0.45
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$23.00
Above
SMA 200
$16.34
Above
RSI (14)
76.4
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+136.5% upside
Current
$34.01
$34.01
Target
$80.43
$80.43
$62.72
$80.43 avg
$106.86
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.56M | 16.69M | 2.76B |
| Net Income | -310,724,803 | -545,450,210 | -140,854,131 |
| Profit Margin | -3,629.2% | -3,447.7% | -5.1% |
| EBITDA | -519,025,505 | -961,720,752 | -182,068,335 |
| Free Cash Flow | — | — | -125,369,781 |
| Rev Growth | -48.7% | -48.7% | -1.7% |
| Debt/Equity | — | — | 0.56 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |